Stay updated on ABT-165 Combo vs Bevacizumab Combo in Metastatic CRC Clinical Trial

Sign up to get notified when there's something new on the ABT-165 Combo vs Bevacizumab Combo in Metastatic CRC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the ABT-165 Combo vs Bevacizumab Combo in Metastatic CRC Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The revision label on the page was updated from v3.4.3 to v3.5.0.
    Difference
    0.0%
    Check dated 2026-03-19T06:10:45.000Z thumbnail image
  2. Check
    11 days ago
    Change Detected
    Summary
    Revision: v3.4.3 replaces v3.4.2. No visible changes to the study page content or its functionality are evident.
    Difference
    0.0%
    Check dated 2026-03-12T01:45:55.000Z thumbnail image
  3. Check
    18 days ago
    No Change Detected
  4. Check
    25 days ago
    No Change Detected
  5. Check
    40 days ago
    Change Detected
    Summary
    Revision: v3.4.2 was added to the page. Outdated funding lapse notices and operating-status messages tied to earlier revisions (v3.4.1) were removed.
    Difference
    0.2%
    Check dated 2026-02-11T14:11:48.000Z thumbnail image
  6. Check
    47 days ago
    Change Detected
    Summary
    Added a government funding notice regarding operations and updated the site revision from v3.4.0 to v3.4.1.
    Difference
    0.2%
    Check dated 2026-02-04T10:22:20.000Z thumbnail image
  7. Check
    54 days ago
    Change Detected
    Summary
    Additions: Show glossary UI element; new labels 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data' with Revision: v3.4.0. Deletions: remove 'Last Update Submitted that met QC Criteria' (lowercase 'met'), 'No FEAR Act data', and the older Revision: v3.3.4.
    Difference
    0.1%
    Check dated 2026-01-28T06:11:19.000Z thumbnail image
  8. Check
    68 days ago
    Change Detected
    Summary
    - Revision: v3.3.4 updated on the page, replacing v3.3.3. This appears to be a non-substantive, cosmetic update that does not alter study details or eligibility.
    Difference
    0.0%
    Check dated 2026-01-14T03:29:36.000Z thumbnail image

Stay in the know with updates to ABT-165 Combo vs Bevacizumab Combo in Metastatic CRC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the ABT-165 Combo vs Bevacizumab Combo in Metastatic CRC Clinical Trial page.